# Atomera Inc (ATOM)

Informational only - not investment advice.

CIK: 0001420520
SIC: 3674 Semiconductors & Related Devices
SIC breadcrumb: [Manufacturing](/division/D/) > [Electronic And Other Electrical Equipment And Components, Except Computer Equipment](/major-group/36/) > [SIC 3674 Semiconductors & Related Devices](/industry/3674/)
Latest 10-K filed: 2026-02-24
SEC page: https://www.sec.gov/edgar/browse/?CIK=1420520
Filing source: https://www.sec.gov/Archives/edgar/data/1420520/000168316826001291/atomera_i10k-123125.htm

## Selected Fundamentals
| Metric | Value | Unit | FY | Filed |
| --- | ---: | --- | ---: | --- |
| Revenue | 65000 | USD | 2025 | 2026-02-24 |
| Net income | -20174000 | USD | 2025 | 2026-02-24 |
| Assets | 21093000 | USD | 2025 | 2026-02-24 |

## Financials

Annual standardized facts from SEC companyfacts as of latest extracted filing date 2026-02-24. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001420520.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts.

| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue |  |  |  |  | 62,000 | 400,000 | 382,000 | 550,000 | 135,000 | 65,000 |
| Net income | -12,610,000 | -13,068,000 | -12,897,000 | -13,300,000 | -14,878,000 | -15,714,000 | -17,441,000 | -19,790,000 | -18,435,000 | -20,174,000 |
| Operating income | -9,999,000 | -13,210,000 | -13,133,000 | -13,625,000 | -14,920,000 | -15,529,000 | -17,526,000 | -20,677,000 | -19,336,000 | -21,123,000 |
| Gross profit | 0.00 | 71,000 | 98,000 | 280,000 | 49,000 | 400,000 | 301,000 | 522,000 | 12,000 | -256,000 |
| Diluted EPS |  |  |  |  |  | -0.70 | -0.75 | -0.80 | -0.68 | -0.65 |
| Operating cash flow | -6,799,000 | -9,289,000 | -9,773,000 | -10,408,000 | -12,067,000 | -12,441,000 | -12,499,000 | -14,557,000 | -13,236,000 | -14,871,000 |
| Capital expenditures | 28,000 | 60,000 | 23,000 | 51,000 | 131,000 | 109,000 | 39,000 | 31,000 | 14,000 | 49,000 |
| Assets | 26,879,000 | 17,807,000 | 19,357,000 | 15,240,000 | 39,395,000 | 36,060,000 | 26,729,000 | 24,029,000 | 29,124,000 | 21,093,000 |
| Liabilities |  |  | 1,611,000 | 1,468,000 | 2,050,000 | 7,679,000 | 6,415,000 | 5,859,000 | 4,047,000 | 2,712,000 |
| Stockholders' equity | 25,848,000 | 16,858,000 | 17,746,000 | 13,772,000 | 37,345,000 | 28,381,000 | 20,314,000 | 18,170,000 | 25,077,000 | 18,381,000 |
| Cash and cash equivalents | 26,718,000 | 17,369,000 | 18,933,000 | 14,871,000 | 37,942,000 | 28,699,000 | 21,184,000 | 12,591,000 | 25,778,000 | 19,210,000 |
| Free cash flow | -6,827,000 | -9,349,000 | -9,796,000 | -10,459,000 | -12,198,000 | -12,550,000 | -12,538,000 | -14,588,000 | -13,250,000 | -14,920,000 |

### Ratios

ROE and ROA use period-end equity/assets. Liabilities / equity uses total liabilities divided by stockholders' equity. Current ratio uses current assets divided by current liabilities when both are reported.

| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Return on equity | -48.79% | -77.52% | -72.68% | -96.57% | -39.84% | -55.37% | -85.86% | -108.92% | -73.51% | -109.75% |
| Return on assets | -46.91% | -73.39% | -66.63% | -87.27% | -37.77% | -43.58% | -65.25% | -82.36% | -63.30% | -95.64% |
| Liabilities / equity |  |  | 0.09 | 0.11 | 0.05 | 0.27 | 0.32 | 0.32 | 0.16 | 0.15 |
| Current ratio | 26.01 | 18.68 | 11.97 | 10.22 | 26.29 | 10.54 | 7.43 | 5.35 | 7.58 | 9.80 |

## Quarterly

Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-05-05. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001420520.json.

Flow metrics use discrete quarter-length periods from 10-Q/10-Q/A filings. Q4 revenue and net income are derived only when annual FY and nine-month YTD facts exist for the same fiscal year; derived Q4 values are labeled. EPS Q4 is not derived.

| Quarter | End date | Revenue | Net income | Diluted EPS | Method |
| --- | --- | ---: | ---: | ---: | --- |
| 2022-Q2 | 2022-06-30 |  |  | -0.20 | reported discrete quarter |
| 2022-Q3 | 2022-09-30 |  |  | -0.20 | reported discrete quarter |
| 2023-Q1 | 2023-03-31 |  |  | -0.21 | reported discrete quarter |
| 2023-Q2 | 2023-03-31 |  | -5,019,000 |  | reported discrete quarter |
| 2023-Q2 | 2023-06-30 | 0.00 |  | -0.21 | reported discrete quarter |
| 2023-Q3 | 2023-06-30 |  | -5,152,000 |  | reported discrete quarter |
| 2023-Q3 | 2023-09-30 | 0.00 |  | -0.20 | reported discrete quarter |
| 2023-Q4 | 2023-12-31 | 550,000 | -4,580,000 |  | derived Q4 = FY annual - nine-month YTD |
| 2024-Q1 | 2024-03-31 | 18,000 | -4,822,000 | -0.19 | reported discrete quarter |
| 2024-Q2 | 2024-03-31 |  | -4,822,000 |  | reported discrete quarter |
| 2024-Q2 | 2024-06-30 | 72,000 |  | -0.16 | reported discrete quarter |
| 2024-Q3 | 2024-06-30 |  | -4,361,000 |  | reported discrete quarter |
| 2024-Q3 | 2024-09-30 | 22,000 |  | -0.17 | reported discrete quarter |
| 2024-Q4 | 2024-12-31 | 23,000 | -4,657,000 |  | derived Q4 = FY annual - nine-month YTD |
| 2025-Q1 | 2025-03-31 | 4,000 | -5,209,000 | -0.17 | reported discrete quarter |
| 2025-Q2 | 2025-03-31 |  | -5,209,000 |  | reported discrete quarter |
| 2025-Q2 | 2025-06-30 | 0.00 |  | -0.17 | reported discrete quarter |
| 2025-Q3 | 2025-06-30 |  | -4,967,000 |  | reported discrete quarter |
| 2025-Q3 | 2025-09-30 | 11,000 |  | -0.17 | reported discrete quarter |
| 2025-Q4 | 2025-12-31 | 50,000 | -4,425,000 |  | derived Q4 = FY annual - nine-month YTD |
| 2026-Q1 | 2026-03-31 | 11,000 | -6,073,000 | -0.17 | reported discrete quarter |

## Macro Cross-References
- [CPIAUCSL](/indicator/CPIAUCSL/): Consumer Price Index for All Urban Consumers: All Items in U.S. City Average
- [UNRATE](/indicator/UNRATE/): Unemployment Rate
- [FEDFUNDS](/indicator/FEDFUNDS/): Federal Funds Effective Rate
- [CES0500000003](/indicator/CES0500000003/): Average Hourly Earnings of All Employees, Total Private
- [DFEDTARU](/indicator/DFEDTARU/): Federal Funds Target Range - Upper Limit
- [DFEDTARL](/indicator/DFEDTARL/): Federal Funds Target Range - Lower Limit
- [DGS3MO](/indicator/DGS3MO/): Market Yield on U.S. Treasury Securities at 3-Month Constant Maturity
- [DGS2](/indicator/DGS2/): Market Yield on U.S. Treasury Securities at 2-Year Constant Maturity
- [DGS10](/indicator/DGS10/): Market Yield on U.S. Treasury Securities at 10-Year Constant Maturity
- [DGS30](/indicator/DGS30/): Market Yield on U.S. Treasury Securities at 30-Year Constant Maturity
- [T10Y2Y](/indicator/T10Y2Y/): 10-Year Treasury Constant Maturity Minus 2-Year Treasury Constant Maturity
- [CPILFESL](/indicator/CPILFESL/): Consumer Price Index for All Urban Consumers: All Items Less Food and Energy
- [CPIUFDSL](/indicator/CPIUFDSL/): Consumer Price Index for All Urban Consumers: Food
- [CPIENGSL](/indicator/CPIENGSL/): Consumer Price Index for All Urban Consumers: Energy
- [CUSR0000SAH1](/indicator/CUSR0000SAH1/): Consumer Price Index for All Urban Consumers: Shelter
- [PCEPI](/indicator/PCEPI/): Personal Consumption Expenditures: Chain-type Price Index
- [PCEPILFE](/indicator/PCEPILFE/): Personal Consumption Expenditures Excluding Food and Energy: Chain-type Price Index
- [PPIACO](/indicator/PPIACO/): Producer Price Index by Commodity: All Commodities
- [T10YIE](/indicator/T10YIE/): 10-Year Breakeven Inflation Rate
- [U6RATE](/indicator/U6RATE/): Total Unemployed, Plus All Marginally Attached Workers Plus Total Employed Part Time for Economic Reasons
- [PAYEMS](/indicator/PAYEMS/): All Employees, Total Nonfarm
- [CIVPART](/indicator/CIVPART/): Labor Force Participation Rate
- [EMRATIO](/indicator/EMRATIO/): Employment-Population Ratio
- [UNEMPLOY](/indicator/UNEMPLOY/): Unemployed
- [CE16OV](/indicator/CE16OV/): Employment Level
- [ICSA](/indicator/ICSA/): Initial Claims
- [JTSJOL](/indicator/JTSJOL/): Job Openings: Total Nonfarm
- [JTSQUR](/indicator/JTSQUR/): Quits: Total Nonfarm
- [GDPC1](/indicator/GDPC1/): Real Gross Domestic Product
- [A191RL1Q225SBEA](/indicator/A191RL1Q225SBEA/): Real Gross Domestic Product: Percent Change from Preceding Period
- [INDPRO](/indicator/INDPRO/): Industrial Production: Total Index
- [TCU](/indicator/TCU/): Capacity Utilization: Total Index
- [HOUST](/indicator/HOUST/): New Privately-Owned Housing Units Started: Total Units
- [PERMIT](/indicator/PERMIT/): New Privately-Owned Housing Units Authorized in Permit-Issuing Places: Total Units
- [RSAFS](/indicator/RSAFS/): Advance Retail Sales: Retail Trade
- [PCE](/indicator/PCE/): Personal Consumption Expenditures
- [DSPIC96](/indicator/DSPIC96/): Real Disposable Personal Income
- [PSAVERT](/indicator/PSAVERT/): Personal Saving Rate
- [M2SL](/indicator/M2SL/): M2
- [BOPGSTB](/indicator/BOPGSTB/): U.S. International Trade in Goods and Services: Balance
- [MSPUS](/indicator/MSPUS/): Median Sales Price of Houses Sold for the United States
- [HSN1F](/indicator/HSN1F/): New One Family Houses Sold: United States
- [RHORUSQ156N](/indicator/RHORUSQ156N/): Homeownership Rate in the United States
- [TTLCONS](/indicator/TTLCONS/): Total Construction Spending: Total Construction in the United States
- [RRVRUSQ156N](/indicator/RRVRUSQ156N/): Rental Vacancy Rate in the United States
- [TOTALSL](/indicator/TOTALSL/): Total Consumer Credit Owned and Securitized
- [REVOLSL](/indicator/REVOLSL/): Revolving Consumer Credit Owned and Securitized
- [DRCCLACBS](/indicator/DRCCLACBS/): Delinquency Rate on Credit Card Loans, All Commercial Banks
- [GDP](/indicator/GDP/): Gross Domestic Product
- [GPDI](/indicator/GPDI/): Gross Private Domestic Investment
- [GCE](/indicator/GCE/): Government Consumption Expenditures and Gross Investment
- [PCEC](/indicator/PCEC/): Personal Consumption Expenditures
- [NETEXP](/indicator/NETEXP/): Net Exports of Goods and Services
- [GFDEBTN](/indicator/GFDEBTN/): Federal Debt: Total Public Debt
- [GFDEGDQ188S](/indicator/GFDEGDQ188S/): Federal Debt: Total Public Debt as Percent of Gross Domestic Product
- [FYFSD](/indicator/FYFSD/): Federal Surplus or Deficit
- [FGRECPT](/indicator/FGRECPT/): Federal Government Current Receipts
- [FGEXPND](/indicator/FGEXPND/): Federal Government: Current Expenditures
- [MANEMP](/indicator/MANEMP/): All Employees, Manufacturing
- [USCONS](/indicator/USCONS/): All Employees, Construction
- [USTRADE](/indicator/USTRADE/): All Employees, Retail Trade
- [USFIRE](/indicator/USFIRE/): All Employees, Financial Activities
- [USGOVT](/indicator/USGOVT/): All Employees, Government
- [AWHAETP](/indicator/AWHAETP/): Average Weekly Hours of All Employees, Total Private
- [DGORDER](/indicator/DGORDER/): Manufacturers' New Orders: Durable Goods
- [NEWORDER](/indicator/NEWORDER/): Manufacturers' New Orders: Nondefense Capital Goods Excluding Aircraft
- [BUSINV](/indicator/BUSINV/): Total Business Inventories
- [EXPGS](/indicator/EXPGS/): Exports of Goods and Services
- [IMPGS](/indicator/IMPGS/): Imports of Goods and Services
- [IR](/indicator/IR/): Import Price Index (End Use): All Commodities
- [PPIFIS](/indicator/PPIFIS/): Producer Price Index by Commodity: Final Demand

## Latest quarter (10-Q)

Latest 10-Q source: https://www.sec.gov/Archives/edgar/data/1420520/000168316826003501/atomera_i10q-033126.htm

Extracted structurally from real Item 2 body heading to real Item 3/4 boundary.
Confidence: high
Filing date: 2026-05-05
Report date: 2026-03-31

Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations

The following discussion and
analysis of the financial condition and results of operations of Atomera Incorporated should be read in conjunction with our financial
statements and the accompanying notes that appear elsewhere in this Quarterly Report on Form 10-Q. Statements in this Quarterly Report
include forward-looking statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives,
expectations and intentions. We use words such as “anticipate,” “estimate,” “plan,” “project,”
“continuing,” “ongoing,” “expect,” “believe,” “intend,” “may,”
“will,” “should,” “could,” and similar expressions to identify forward-looking statements. Although
forward-looking statements in this Quarterly Report reflect the good faith judgment of our management, such statements can only be based
on facts and factors currently known by us. Consequently, forward-looking statements are inherently subject to risks, uncertainties, and
changes in condition, significance, value and effect, including those risk factors set forth in our Annual Report on Form 10-K for the
year ended December 31, 2025 filed with the SEC on February 24, 2026. Such risks, uncertainties and changes in condition, significance,
value and effect could cause our actual results to differ materially from those expressed herein and in ways not readily foreseeable.
Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this Quarterly Report
and are based on information currently and reasonably known to us. We undertake no obligation to revise or update any forward-looking
statements in order to reflect any event or circumstance that may arise after the date of this Quarterly Report. Readers are urged to
carefully review and consider the various disclosures made in this Quarterly Report, which attempt to advise interested parties of the
risks and factors that may affect our business, financial condition, results of operations and prospects.

Overview

We are engaged in the business
of developing, commercializing and licensing proprietary processes and technologies for the $700+ billion semiconductor industry. Our
lead technology, named Mears Silicon Technology™, or MST®, is a thin film of reengineered silicon. MST is our proprietary
and patent-protected performance enhancement technology that we believe addresses a number of key engineering challenges facing the semiconductor
industry. MST provides multiple benefits to the semiconductor manufacturing process, enabling transistors to be made smaller, with increased
speed, reliability and power efficiency. In addition, since MST is an additive and low-cost technology, we believe it can be deployed
on an industrial scale, with machines commonly used in semiconductor manufacturing. We believe that MST can be widely incorporated into
the most common types of semiconductor products, including analog, logic, optical and memory integrated circuits. 

We do not design or manufacture
wafers or integrated circuits directly. Instead, we develop and license technologies and processes that we believe offer the designers
and manufacturers of wafers and integrated circuits a low-cost solution to the industry’s need for greater performance and lower
power consumption. Our customers and partners include:

·

foundries, which manufacture integrated circuits on behalf of fabless manufacturers;

·

integrated device manufacturers, or IDMs, which are the fully-integrated designers and manufacturers of integrated circuits;

·

fabless semiconductor manufacturers, which are designers
of integrated circuits that outsource the manufacturing of their chips to foundries;

·

manufacturers of semiconductor wafers, which provide the substrates upon which integrated circuits are fabricated;

·

original equipment manufacturers, or OEMs, that manufacture the epitaxial, or epi, machines used to deposit semiconductor layers, such as the MST film, onto silicon wafers; and

·

electronic design automation companies, which make tools used throughout the industry to simulate performance of semiconductor products using different materials, design structures and process technologies.

18

Our principal business objective
is to enter into commercial license agreements that enable our customers to manufacture and sell MST-enabled products, generating license
revenues and ongoing royalties. We also license our MSTcad® software to customers, enabling them to simulate the effects
of MST on their products using Synopsys, Inc.’s technology computer-aided design, or TCAD, software. In addition, we offer fee-based
integration engineering services to customers to evaluate the effects of MST as integrated into their manufacturing flow. Typically, we
offer these services through paid evaluation arrangement, joint development agreements (“JDAs”) or integration license agreements.

Our goal is that MSTcad licensing
and engineering service arrangements will be tools that demonstrate the benefits of MST when integrated into customers’ manufacturing
processes and will lead customers to enter into commercial license agreements. A “commercial license” consists of (i) an R&D
license, which grants our customer the rights to install MST on a tool in their fab and to manufacture MST-enabled products, but only
for internal use and limited customer sampling and (ii) a high-volume manufacturing, or HVM, license which grants the rights to manufacture
and sell MST-enabled products to their customers.

Depending upon our customers’
business needs and how we initially engaged with them, we may make these license grants in one or more separate contracts. Our preferred
model is to charge our customers upfront license fees for each license grant. Under our licensing model, the R&D license fee is due
upon installation of MST in a tool at our customer’s fab and a larger HVM license fee will be due when our customer completes qualification
of MST in their process and before they can sell MST -enabled products to their customers. Upon the grant of an HVM license, our licensees
are also required to make royalty payments to us based on the number and/or sales price of MST-enabled products they sell. We have engaged
with certain customers under joint development agreements, or JDAs. Our JDAs include development, technology transfer, manufacturing and
licensing components.

To date, applications of our MST
technology have primarily been for power devices, RFSOI devices and advanced CMOS integrated circuits including logic and memory. CMOS
integrated circuits are the most widely used type of integrated circuits in the semiconductor industry. We believe MST has the potential
to overcome the key challenges found in the implementation of next-generation nano-scale semiconductor devices incorporating CMOS type
transistors, namely enhancing drive current, reducing leakage and reducing variability. In addition, we believe that MST has the potential
to deliver these benefits through a single technology that requires relatively minor modifications to the industry-standard CMOS manufacturing
flow. Consequently, we believe that by incorporating MST, designers can make transistors with increased speed, reliability and energy
efficiency, without significantly altering the current fabrication process or cost of production.

Starting in 2024, we began applying
our technology to wafers used for fabrication of “compound semiconductors” which are devices built using materials other than
silicon, such as gallium nitride (GaN), which have properties especially attractive to the power and radio frequency markets. Currently,
materials such as GaN suffer from a tradeoff between high-cost specialized wafers and defective, low-yielding wafers resulting from the
crystal lattice mismatch between heterogeneous materials. We believe MST can offer a cost-effective solution to these tradeoffs by serving
as a buffer layer between different materials, such as between GaN and a silicon wafer substrate.

We were organized as a Delaware
limited liability company under the name Nanovis LLC on November 26, 2001. On March 13, 2007, we converted to a Delaware corporation under
the name Mears Technologies, Inc. On January 12, 2016, we changed our name to Atomera Incorporated. Shares of our common stock are listed
on the NASDAQ Capital Market under the symbol “ATOM”.

On May 31, 2022, we entered into
an Equity Distribution Agreement with Oppenheimer & Co. Inc. and Craig-Hallum Capital Group LLC (“Craig-Hallum”), as agents,
under which we offered and sold, from time to time at our sole discretion, shares of our common stock in an at the market offering to
or through the agents, having aggregate offering proceeds of up to $50.0 million (the “2022 ATM”). The 2022 ATM expired on
March 18, 2025.

On May 27, 2025, we entered into
an Equity Distribution Agreement Craig-Hallum as agent, under which we may offer and sell, from time to time at our sole discretion, shares
of our common stock in an “at-the-market” offering, (the “2025 ATM”) to or through the agent, having aggregate
offering proceeds of up to $50.0 million. During the three months ended March 31, 2026, we sold approximately 1.3 million shares pursuant
to the 2025 ATM at an average price per share of approximately $2.47 resulting in approximately $3.1 million of net proceeds to us after
deducting commissions and other offering expenses.

19

On February 24, 2026, we completed
a registered direct offering (the “Offering”) of 5,000,000 shares of our common stock at a purchase price of $5.00 per share
pursuant to a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional investors. In connection
with the Offering, the Company entered into a placement agent agreement with Craig-Hallum, pursuant to which Craig-Hallum served as the
exclusive placement agent for the issuance and sale of securities of the Company pursuant to the Purchase Agreement. As compensation for
such placement agent services, the Company paid Craig-Hallum an aggregate cash fee equal to 5.0% of the gross proceeds received by the
Company from the Offering and agreed to reimburse up to $75,000 of legal and other expenses actually incurred. Net proceeds to the
Company after deducting the placement agent fee and expenses were approximately $23.6 million.

Results of Operations

Revenues. To date, we have
only generated limited revenue from customer engagements for engineering services, integration license agreements, R&D licenses granted
under a JDA and under our license agreement with ST Microelectronics and licensing of MSTcad. Our MSTcad licenses grant customers the
right to use MSTcad software to simulate the effects of incorporating MST technology into their semiconductor manufacturing process. MSTcad
licenses are granted on a monthly or yearly basis and revenue is recognized over time.

Revenue for the three months ended
March 31, 2026 and 2025 was approximately $11,000 and $4,000, respectively. Our revenue for the period ended March 31, 2026, consisted
of engineering services revenue from the delivery of MST wafers. Revenue for the period ended March 31, 2025 consisted of MSTcad licensing
and related consulting services revenue.

Cost of revenue. Cost of
revenue consists of costs of materials, as well as direct compensation and expenses incurred to deliver wafers and perform services, and
consulting services provided for our MSTcad licenses. Cost of revenue for the three months ended March 31, 2026 was approximately $126,000.
No cost of revenue was recorded for the three months ended March 31, 2025. We anticipate that our cost of revenue will vary substantially
depending on the mix of license and engineering services revenues we receive and the nature of products and/or services delivered in each
customer engagement. Cost of revenue is expensed when incurr

[Excerpt truncated for page length; source filing is linked above.]

## Latest 10-K MD&A

Extracted from Item 7 to the first post-MD&A boundary after HTML sanitization.
Confidence: high

Item 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion
and analysis of the financial condition and results of operations of Atomera Incorporated should be read in conjunction with our financial
statements and the accompanying notes that appear elsewhere in this Annual Report. Statements in this Annual Report on Form 10-K include
forward-looking statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives, expectations
and intentions. We use words such as “anticipate,” “estimate,” “plan,” “project,” “continuing,”
“ongoing,” “expect,” “believe,” “intend,” “may,” “will,” “should,”
“could,” and similar expressions to identify forward-looking statements. Although forward-looking statements in this Annual
Report reflect the good faith judgment of our management, such statements can only be based on facts and factors currently known by us.
Consequently, forward-looking statements are inherently subject to risks, uncertainties, and changes in condition, significance, value
and effect, including those risk factors set forth in this Annual Report. Such risks, uncertainties and changes in condition, significance,
value and effect could cause our actual results to differ materially from those expressed herein and in ways not readily foreseeable.
Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this Annual Report
and are based on information currently and reasonably known to us. We undertake no obligation to revise or update any forward-looking
statements in order to reflect any event or circumstance that may arise after the date of this Annual Report. Readers are urged to carefully
review and consider the various disclosures made in this Annual Report, which attempt to advise interested parties of the risks and factors
that may affect our business, financial condition, results of operations and prospects.

21

Overview

We are engaged in the business
of developing, commercializing and licensing proprietary processes and technologies for the $700+ billion semiconductor industry. Our
lead technology, named Mears Silicon Technology™, or MST®, is a thin film of reengineered silicon, typically 100
to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST is our proprietary and patent-protected performance
enhancement technology that we believe addresses a number of key engineering challenges facing the semiconductor industry. We believe
that by incorporating MST, transistors can be made smaller, with increased speed, reliability and power efficiency. In addition, since
MST is an additive and low-cost technology, we believe it can be deployed on an industrial scale, with machines commonly used in semiconductor
manufacturing. We believe that MST can be widely incorporated into the most common types of semiconductor products, including analog,
logic, optical and memory integrated circuits.

We do not design or manufacture
integrated circuits directly. Instead, we develop and license technologies and processes that we believe offer the designers and manufacturers
of integrated circuits a low-cost solution to the industry’s need for greater performance and lower power consumption. Our customers
and partners include:

·

foundries, which manufacture integrated circuits on behalf of fabless manufacturers;

·

integrated device manufacturers, or IDMs, which are the fully-integrated designers and manufacturers of integrated circuits;

·

fabless semiconductor manufacturers, which are designers of integrated circuits that outsource the manufacturing of their chips to foundries;

·

Manufacturers of semiconductor wafers, which provide
the substrates upon which integrated circuits are fabricated:;

·

original equipment manufacturers, or OEMs, that manufacture the epitaxial, or epi, machines used to deposit semiconductor layers, such as the MST film, onto silicon wafers; and

·

electronic design automation companies, which make tools used throughout the industry to simulate performance of semiconductor products using different materials, design structures and process technologies.

Our commercialization strategy
is to generate revenue through licensing arrangements whereby foundries, IDMs and fabless semiconductor manufacturers pay us a license
fee for their right to use MST technology in the manufacture of silicon wafers as well as a royalty for each silicon wafer or device that
incorporates our MST technology. We also license our MSTcad software to our customers for use in simulating the effects of using MST technology
on their wafers and/or devices. To date, we have generated revenue from (i) licensing agreements with ST and AKM, both of which are IDMs,
one fabless manufacturer and one foundry, (ii) a joint development agreement, or JDA, with a leading semiconductor provider, (iii) engineering
services provided to foundries, IDMs and fabless companies and (iv) licensing MSTcad.

We were organized as a Delaware
limited liability company under the name Nanovis LLC on November 26, 2001. On March 13, 2007, we converted to a Delaware corporation under
the name Mears Technologies, Inc. On January 12, 2016, we changed our name to Atomera Incorporated.

On May 31, 2022, we entered
into an Equity Distribution Agreement with Oppenheimer & Co. Inc. and Craig-Hallum Capital Group LLC (“Craig-Hallum”),
as agents, under which we offered and sold, from time to time at our sole discretion, shares of our common stock in an at the market offering
to or through the agents, having aggregate offering proceeds of up to $50.0 million (the “2022 ATM”). The 2022 ATM expired
on March 18, 2025.

22

On May 27, 2025, we entered
into an Equity Distribution Agreement with Craig-Hallum as agent, under which we may offer and sell, from time to time at our sole discretion,
shares of our common stock in an “at-the-market” offering to or through the agent, having aggregate offering proceeds of up
to $50.0 million (the “2025 ATM”).

During the year ended December
31, 2025, we sold approximately 1.6 million shares pursuant to the 2022 ATM and the 2025 ATM at an average price per share of approximately
$5.15, resulting in approximately $7.6 million of net proceeds to us after deducting commissions and other offering expenses.

On February 23, 2026, we entered
into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional investors pursuant to which we
agreed to issue and sell, in a registered direct offering (the “Offering”), an aggregate of 5,000,000 shares of our common
stock, at a purchase price of $5.00 per share, for gross proceeds from the Offering of $25 million, before deducting the placement agent
fee and estimated offering expenses. On February 24, 2026 we closed the Offering, resulting in net proceeds to us of approximately
$23.6 million after commissions and expenses.

Results of Operations for the Years Ended December
31, 2025 and 2024

Revenues. To
date, we have only generated limited revenue from customer engagements for engineering services, integration license agreements, R&D
licenses granted under a JDA and under our license agreement with ST and licensing of MSTcad. Our MSTcad licenses grant customers the
right to use MSTcad software to simulate the effects of incorporating MST technology into their semiconductor manufacturing process. MSTcad
licenses are granted on a monthly or yearly basis and revenue is recognized over time.

For recognizing integration
service revenue from integration license agreements, we assess (i) whether the license grant is distinct from or combined with the transfer
of goods or services and (ii) whether the license is a right to access intellectual property or a right to use the intellectual property.
For licenses that are not distinct, but combined with other goods or services, the revenue is recognized at a point in time or over time
as the obligations to perform the combined services and/or deliver the combined goods are satisfied. Our engineering service agreements
contain a technology grant as well as a performance obligation to deliver wafers with our technology deposited on them. We have historically
determined the grant of rights in these agreements is not distinct from the obligation to deliver wafers and accordingly, revenue from
these agreements is recognized at the time we deliver wafers. For R&D licenses, revenue is recognized at the point in time when we
deliver our MST recipe because the license to manufacture products using MST technology is a right to use the Company’s technology
and not a right to access the technology over time. However, in cases where our R&D license grants include a customer acceptance requirement,
revenue is recognized over time. Likewise, we recognize revenue from HVM licenses at the point in time when process qualification is complete
because the license to sell MST-enabled products is a right to use the Company’s technology and not a right to access the technology
over time.

Revenue for the years ended
December 31, 2025 and 2024 was approximately $65,000 and $135,000, respectively. Our revenue in 2025 and 2024 consisted of MSTcad licensing
and related consulting services revenue, and engineering services revenue from the delivery of MST wafers.

Cost of Revenue. Cost
of revenue consists of costs of materials, as well as direct compensation and expenses incurred to provide integration engineering services,
support for customer installation and qualification and MSTcad support. Cost of revenue was approximately $321,000 and $123,000 for the
years ended December 31, 2025 and 2024, respectively. Cost of revenue is recorded when incurred and may not coincide with the recognition
of revenue based on revenue recognition policies and guidance. We anticipate that our cost of revenue will vary substantially depending
on the mix of license and engineering services revenues we receive and the nature of products and/or services delivered in each customer
engagement.

Operating Expenses.
Operating expenses consist of research and development, general and administrative, and selling and marketing expenses. For the
years ended December 31, 2025 and 2024, our operating expenses totaled approximately $20.9 million and $19.3 million, respectively.

Research and development
expenses. To date, our operations have focused on the research, development, and commercialization of our MST technology and related
technologies such as MSTcad. Our research and development costs primarily consist of payroll and benefit costs for our engineering staff
and costs of outsourced fabrication (including epi tool leases) and metrology of semiconductor wafers incorporating our MST technology.

23

For the years ended December
31, 2025 and 2024, we incurred approximately $12.3 million and $11.0 million, respectively, of research and development expense, an increase
of approximately $1.3 million, or 12%. This increase was primarily due to an increase of approximately $676,000 in outsourced fabrication
costs as well as increases of approximately $487,000 in stock-based compensation expenses and approximately $124,000 in employee-related
expenses. Stock-based compensation expenses increased primarily due to our adoption of performance-based RSUs for executives, which have
a higher valuation than time-based RSUs and options which had been our primary type of executive equity compensation issued in 2024.

General and administrative
expenses. General and administrative expenses consist primarily of payroll and benefit costs for administrative personnel, office-related
costs and professional fees. General and administrative costs for the years ended December 31, 2025 and 2024 were approximately $7.8 million
and $7.3 million, respectively, representing an increase of approximately $540,000, or 7%. The increase in costs was primarily due to
an increase in stock-based compensation expense of approximately $810,000 and an approximately $114,000 increase in corporate legal fees,
partially offset by a decline of approximately $421,000 in employee-related costs. Stock-based compensation expenses increased primarily
due to an increase in the valuation of performance based

RSUs newly issued this year compared to time-based RSUs and options. The decrease in employee-related costs is primarily due to a reduction
in executive annual bonus accrual.

Selling and marketing
expenses. Selling and marketing expenses consist primarily of salary and benefits for our sales and marketing personnel and business
development consulting services. Selling and marketing expenses for the years ended December 31, 2025 and 2024 were approximately $758,000
and $1.1 million, respectively, representing a decrease of approximately $295,000, or 28%. The decrease in costs is primarily related
to a reduction in headcount which decreased employee-related costs, stock-based compensation and travel expenses, partially offset by
increases in recruiting costs to fill open positions.

Interest income. Interest
income for the years ended December 31, 2025 and 2025 was approximately $931,000 and $779,000, respectively, an increase of approximately
$152,000, or 20%. Interest income reflects interest earned on our cash, cash equivalents and short-term investments and are impacted by
current interest rates and average balances over the periods presented.

Accretion income.
Accretion income for the years ended December 31, 2025 and 2024 was approximately $6,000 and $178,000, respectively. Accretion income
relates to the increase in value of our available-for-sale securities from the purchase date through the maturity date. Accretion
income relates to the increase in value of our available-for-sale securities from the purchase date through the maturity date. As of December
31, 2025, our cash and cash equivalents were held as cash and mutual funds.

Other income/expense,
net. Other income for the years December 31, 2025 and 2024 was approximately $72,000 and $73,000, respectively. Other income consisted
primarily of a refundable state research and development tax credit, net of filing costs and tax consulting services for both years.

Interest expense. Interest
expense for the years ended December 31, 2025 and 2024 was approximately $60,000 and $129,000, respectively. Interest expense is related
to the tool financing lease entered into in August 2021.

Liquidity and Capital Resources

As of December 31, 2025, we
had cash and cash equivalents of approximately $19.2 million and working capital of approximately $17.6 million. For the year ended December
31, 2025, we had a net loss of approximately $20.2 million and used approximately $14.9 million of cash and cash equivalents in operations.
Since inception, we have incurred recurring operating losses. On February 24, 2026, we closed on the sale of 5,000,000 shares of our common
stock, at a price of $5.00 per share, in a registered direct offering for the net proceeds of approximately $23.6 million after commissions
and offering expenses.

During the year ended December
31, 2025, we sold approximately 1.6 million shares of our common stock pursuant to our 2022 and 2025 ATM facilities at an average price
per share of approximately $5.15, resulting in approximately $7.6 million of net proceeds to us after deducting commissions and other
offering expenses.

24

We believe that our available
working capital as of the date of this report, and after giving effect to our February 2026 registered direct offering, is sufficient
to fund our presently forecasted working capital requirements for, at least, the next 24 months following the date of the filing of this
report. However, our future capital requirements and the adequacy of our available funds will depend on many factors, including our ability
to successfully commercialize our MST technology, competing technological and market developments, and the need to enter into collaborations
with other companies or acquire technologies to enhance or complement our current offerings. If we are not able to generate sufficient
revenue from license fees and royalties in a time frame that satisfies our cash needs, we will need to raise more capital. In the event
we require additional capital, we will endeavor to acquire additional funds through various financing sources, including our ATM Facility,
follow-on equity offerings, debt financing and joint ventures with industry partners. In addition, we will consider alternatives to our
current business plan that may enable us to achieve revenue-producing operations and meaningful commercial success with a smaller amount
of capital. If we are unable to secure additional capital, we may be required to curtail our research and development initiatives and
take additional measures to reduce costs in order to conserve our cash.

Cash Flows from Operating, Investing and Financing
Activities:

Net cash used in operating
activities of approximately $14.9 million for year ended December 31, 2025 resulted primarily from our net loss of approximately $20.2
million, adjusted by approximately $5.0 million of stock-based compensation expense.

Net cash used in operating
activities of approximately $13.2 million for year ended December 31, 2024 resulted primarily from our net loss of approximately $18.4
million, adjusted by approximately $3.9 million of stock-based compensation expense and amortization of right-of-use assets of approximately
$1.3 million.

Net cash provided in investing
activities of approximately $951,000 for year ended December 31, 2025 consisted primarily of the maturity of short-term available-for-sale
investments, offset by the acquisition of property and equipment.

Net cash provided in investing
activities of approximately $6.1 million and for year ended December 31, 2024 consisted primarily of the maturity of short-term available-for-sale
investments, offset by the purchase of short-term available-for-sale investments.

Net cash provided by financing
activities of approximately $7.4 million for the year ended December 31, 2025 related primarily to net proceeds from our ATM Facility
and the exercise of stock options, offset in part by approximately $1.2 million in principal payments on our financing lease.

Net cash provided by financing
activities of approximately $20.3 million for the year ended December 31, 2024 related primarily to net proceeds from our ATM Facility,
offset in part by approximately $1.1 million in principal payments on our financing lease.

Critical Accounting Estimates

Our financial statements are
prepared in accordance with accounting principles generally accepted in the United States. The preparation of financial statements in
conformity with those accounting principles requires us to use judgment in making estimates and assumptions based on the relevant information
available at the end of each period. These estimates and assumptions have a significant effect on reported amounts of assets, liabilities,
sales and expenses as well as the disclosure of contingent assets and liabilities because they result primarily from the need to make
estimates and assumptions on matters that are inherently uncertain. Actual results could differ from our estimates.

25

Leases

We account for leases in accordance
with Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No 2016-02, Leases
(Topic 842). We determine if a contract contains a lease in whole or in part at the inception of the contract. Right-of-use (“ROU”)
assets represent our right to use an underlying asset for the lease term while lease liabilities represent our obligation to make lease
payments arising from the lease. All leases greater than 12 months result in the recognition of a ROU asset and a liability at the lease
commencement date based on the present value of the lease payments over the lease term. Lease expenses for operating leases is recognized
on a straight-line-basis over the lease term. Lease expenses for financing leases consists of amortization of the ROU assets over the
life of the lease and interest expense is recognized on the liability.

Stock-based Compensation

We have stock-based compensation
programs, which include restricted stock awards (“RSAs”), Restricted stock Units (“RSUs”) and stock options and
an employee stock purchase plan. We account for stock-based compensation expense, including the expense for grants of RSAs and stock options
that may be settled in shares of our common stock, based on the fair values of the equity instruments issued. The fair value is determined
on the measurement date, which is the date of grant. The fair value of our RSAs is measured at the market price of our common stock on
the measurement date amortized over the vesting period of the award. The fair value of our time-based RSUs is based on the closing price
on the day of grant and they vest over zero to four years. Awards of performance-based restricted stock units we issue have a performance
period of one, two and three years with the vesting of each award tranche dependent on our Total Shareholder Return (“TSR”)
relative to the TSR of companies in the Russell 2000 Index over that tranche’s performance period. The fair value for performance-based
awards is fixed at the grant date using a Monte Carlo simulation and the amount of compensation expense is not adjusted during the performance
period regardless of changes in the level of TSR achievement. The fair value for our stock option awards is determined at the grant date
using the Black-Scholes Option Pricing Model and amortized over the vesting period of the option.

Assumptions
for the Black-Scholes valuation model used for employee stock awards include:

·

Expected term – We derived the expected term for employee stock awards using historical information to develop expectations about future exercise patterns and behavior after employment termination.

·

Expected volatility – Volatility is estimated using Atomera’s historical volatility for similar terms.

·

Expected dividend rate – We have not declared or paid dividends to our stockholders and have no plans to pay dividends; therefore, we have assumed an expected dividend yield of 0%.

·

Risk-free interest rate – The risk-free interest rate is based on the yields of U.S. Treasury securities with maturities similar to the expected terms of the associated awards.

·

The fair value of our common stock is measured at the market price on the measurement date.